What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Professionals Miriam Mota Foix Soy técnica estadística en la Unidad de Estadística y Bioinformática (UEB) del Instituto de Investigación del Vall d'Hebron (VHIR) Professionals Santiago Casas Guasch Professionals Maria del Mar Garcia Gil Professionals Silvia Bourdelande Calzado Professionals Laura Planells Ferrer Professionals Elisa Bernadás Caus Professionals Belén Moro I am a Project Manager specialized in pre-award processes and research talent programmes. I manage full grant cycles, support researchers, and coordinate with institutional teams to ensure high-quality submissions. I bring a scientific background, strong analytical skills, and a clear focus on effic Professionals Tatiana Camila Sanabria Professionals Karina Noemi Agüero Jimenez A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection Open Protocol code: BMX-04-002 EudraCT code: No aplica Research group: Pneumology Service: Pneumology Principal investigator: Álvarez Fernandez, Antonio Pathology: Certes malalties infeccioses i parasitàries Phase: Fase II Status: Recruiting volunteers Estudio de fase Ib, abierto y de dosis ascendente para evaluar la seguridad, la tolerabilidad y la farmacocinética de PIT565 en participantes con artritis reumatoide (AR). Open Protocol code: CPIT565C12101 EudraCT code: No aplica Research group: Rheumatology Service: Rheumatology Principal investigator: Lopez Lasanta, Maria America Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Phase: Fase I Status: Recruiting volunteers AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3,DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTEREDIBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZEDSYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHOARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS Open Protocol code: C5091017 EudraCT code: No aplica Research group: Infectious Diseases Service: Infectious Principal investigator: Len Abad, Oscar Pathology: Certes malalties infeccioses i parasitàries Phase: Fase III Estudio de fase 2b, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de tulisokibart en participantes con hidradenitis supurativa moderada o grave Open Protocol code: MK-7240-012 EudraCT code: No aplica Research group: Biomedical Research in Melanoma Service: Dermatologia Principal investigator: Mollet Sánchez, Jordi Pathology: Malalties de la pell i del teixit subcutani Phase: Fase II Status: Recruiting volunteers A phase 2, multicentre, open-label, single arm study to evaluate theeffectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonaryaspergillosis (CPA) in patients with limited treatment options. Open Protocol code: MR907-2502 EudraCT code: No aplica Research group: Infectious Diseases Service: Infectious Principal investigator: Len Abad, Oscar Pathology: Certes malalties infeccioses i parasitàries Phase: Fase II Status: Recruiting volunteers Estudio de fase 3, aleatorizado, doble ciego y con doble simulación para evaluar la eficacia y la seguridad del empasiprubart frente a inmunoglobulina intravenosa en adultos con neuropatía motora multifocal Open Protocol code: ARGX-117-2302 EudraCT code: No aplica Research group: Peripheral Nervous System Service: Neurology Principal investigator: Juntas Morales, Raul Pathology: Malalties del sistema nerviós Phase: Fase III Status: Recruiting volunteers Estudio en fase III multicéntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralels para evaluar la eficacia, la seguridad y la tolerabilidad de cenerimod además de la terapia de base en pacientes adultos con lupus eritematoso sistémico (LES) moderado a severo. Open Protocol code: ID-064A302 EudraCT code: 2022-002815-47 Research group: Rheumatology Service: Rheumatology Principal investigator: Cortes Hernandez, Josefina Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Phase: Fase III Professionals Elvira Sepulveda Duran Professionals Maria Teresa Rodriguez Acebes Professionals Biel Muñoz Tardà Professionals Anna Ferrer Salvador Pagination First page « Previous page ‹ … Page 2498 Page 2499 Current page 2500 Page 2501 Page 2502 … Next page › Last page »
